Table 3.
Inter and intra-group comparison by symptom grouping
|
NRS-101 Baseline |
NRS-101 48-hour F/U |
|
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sub-group | mean | 95% CI | median | 95% CI | mean | 95% CI | median | 95% CI | Within-group comparison (p-value) | Between-group comparison (p-value) | ||||
| S DDN |
5.59 |
4.68 |
6.50 |
5.00 |
4.00 |
7.00 |
3.41 |
2.31 |
4.52 |
4.00 |
2.01 |
4.99 |
0.011* |
S DDN vs As DDN p<0.0001 |
| S SDN |
5.40 |
4.48 |
6.32 |
5.00 |
4.12 |
6.88 |
4.60 |
3.62 |
5.58 |
4.50 |
3.12 |
6.00 |
0.003* |
|
| As DDN |
0.24 |
0.00 |
0.48 |
0.00 |
0.00 |
0.00 |
0.71 |
0.10 |
1.33 |
0.00 |
0.00 |
0.55 |
0.041 |
|
| As SDN | 0.26 | 0.00 | 0.53 | 0.00 | 0.00 | 0.00 | 0.26 | 0.00 | 0.65 | 0.00 | 0.00 | 0.00 | 0.040 | |
S= Symptomatic, As= Asymptomatic, DDN= deep dry needling, SDN= superficial dry needling.
*P-values remained significant at the 0.05 threshold after Bonferroni multiple test adjustment.